A recent study studied the patterns in the incidence of early-onset cancers between 2010 and 2019 in the United States.
12 people changing the course of the Chinese biopharma industry
From antibody-drug conjugates to immuno-oncology checkpoint inhibitors, China is the world’s most closely watched rising biotechnology power. The growth of China’s industry can be attributed
October 7, 2024